Class II · Moderate risk Terminated
Calcium Chloride 100mg/Ml
Reason Lack of Assurance of Sterility
FDA Drug Recalls
11,815 recalls · Class II, newest first
Class II · Moderate risk Terminated
Buffered Lidocaine HCL 1% Injection Sol
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Buffered Lidocaine HCL 1% Injection Solution
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Buffered Lidocaine 1%+epi 1:100
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Avastin
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Ascorbic Acid 500 MG/ML
Reason Crystallization
Class II · Moderate risk Terminated
Ascorbic Acid 400 MG/ML
Reason Crystallization
Class II · Moderate risk Terminated
Ascorbic Acid 500 MG/ML
Reason Crystallization
Class II · Moderate risk Terminated
SUCCINYLcholine Chloride
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
SUCCINYLcholine Chloride
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Sodium Bicarbonate INJ 8.4%
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Riboflavin 5-Phosphate Sodium Ophthalmic Solution
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Phenylephrine HCL PF INJ in 0.9% Sodium Chloride
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Orphenadrine Citrate Sterile Injectable Solution *Contains Sulfites*
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Neostigmine Methylsulfate
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Naloxone HCL Preserved INJ
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Mitomycin Preservative Free Irrigation
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Isoproterenol HCL in D5W
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Isoproterenol HCL in D5W
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Isoproterenol HCL in D5W
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Droperidol Injectable Sterile Solution
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Dexamethasone Sodium Phosphate Preservative Free Sterile Solution for INJ
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
ChlorproMAZINE HCL INJ
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Class II · Moderate risk Terminated
Brilliant Blue Ophthalmic PF INJ
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.